Vinyas Innovative Technologies Ltd

- No explicit mention of any new fundraising through debt or equity in the call transcript. - Current debt-to-equity ratio stands healthy at 0.7x. - Company has sufficient unutilized non-fund based bank limits for working capital and operational readiness. - Incremental CAPEX plans primarily focus on adding SMT lines (~Rs. 30 crore per line) and small critical equipment (~Rs. 2-3 crore yearly). - Working capital is currently sufficient to support growth for this and next financial year, with advances from customers helping the requirement. - Any major future financing needs will be assessed and communicated later as per evolving business needs.

- Incremental CAPEX mainly involves adding more SMT lines, with a rule of thumb of Rs. 600 crores revenue per SMT line on defense and aerospace side. - Recent expansion involved Rs. 30 crores CAPEX to add a second SMT line; similar level expected for each new line. - Yearly CAPEX of Rs. 2-3 crores planned for other critical equipment to support programs. - Current capacity expansion can support Rs. 1,200 to Rs. 1,400 crores revenue without major additional CAPEX. - Working capital is sufficient for this and next financial year; additional funding to be explored afterward as needed. - No major backward integration CAPEX currently planned, as electronic components are low volume and predominantly imported. - Future investments also include equipment upgrades for quality and process improvements as programs mature.

- Vinyas expects a 25% year-on-year revenue growth for FY ’26. - Current order inflow is expected to be at similar levels as FY ’25, around Rs. 600 to 750 crores. - The confirmed order book is anticipated to grow from Rs. 1,018 crores to about Rs. 1,500 to 1,600 crores by the end of FY ’26. - Full optimal utilization of current capacity is expected by FY ’27. - Current capacity can support Rs. 1,200 to 1,400 crores in revenue without incremental investment. - The company targets Rs. 1,000+ crore revenue by FY ’27 but is cautious in committing exact figures. - There is a 25%-30% year-on-year growth projected over the next few years. - Order execution timelines span 12 to 18 months primarily. - Expansion into new segments like commercial aerospace and medical devices aims to support growth.

- Vinyas Innovative Technologies anticipates 25% year-on-year revenue growth for FY '26. - EBITDA margin is expected to remain stable between 9% to 11% over the next 2-3 years. - Net profit growth of 27% was achieved in FY '25, indicating strong profitability momentum. - EPS for FY '25 was 15.43, with a second half EPS of 9.86, reflecting improved performance. - The margin profile is expected to stay consistent for the next two to three years with operational efficiencies. - Potential margin improvement is limited in the near term; any increases would take more time. - The company plans to leverage growth from defense and aerospace sectors and the medical device segment. - Working capital and capacity expansions are in line to support growing order books without significant margin dilution.

- Current order book stands at about Rs. 1,018 crores as of June 4, 2025. - Execution timeline for the order book is between 12 to 18 months. - Order inflow expected in FY '26 is between Rs. 600 to 750 crores, similar to FY '25 levels. - The confirmed order book is expected to grow to about Rs. 1,500 to 1,600 crores by the end of FY '26, reflecting 25% growth. - The order book composition is roughly 80% defense, 15-18% industrial, and the balance medical. - Approximately 80% of the order book pertains to Make in India programs, with most offset programs having largely completed. - Export orders make up about 22-23% of the current orders. - No substantial development has occurred this financial year on the build-to-spec side for medical devices.